tizanidine may increase the bradycardic activities of Ivabradine.


ALFENTANIL may increase the bradycardic activities of celiprolol.


metoclopramide may increase the bradycardic activities of nadolol.


physostigmine may increase the bradycardic activities of propranolol.


amiodarone may increase the bradycardic activities of BISOPROLOL.


Tofacitinib may increase the bradycardic activities of digoxin.


Echothiophate may increase the bradycardic activities of nadolol.


sotalol may increase the bradycardic activities of digitoxin.


Isoflurophate may increase the bradycardic activities of ESMOLOL.


alprenolol may increase the bradycardic activities of digitoxin.


disopyramide may increase the bradycardic activities of BOPINDOLOL.


malathion may increase the bradycardic activities of acebutolol.


disopyramide may increase the bradycardic activities of CARTEOLOL.


BENDROFLUMETHIAZIDE may increase the bradycardic activities of ceritinib.


succinylcholine may increase the bradycardic activities of Methadyl acetate.


donepezil may increase the bradycardic activities of carvedilol.


Bretylium may increase the bradycardic activities of DEXMEDETOMIDINE.


Lanreotide may increase the bradycardic activities of Crizotinib.


Regorafenib may increase the bradycardic activities of labetalol.


succinylcholine may increase the bradycardic activities of HEROIN.


alprenolol may increase the bradycardic activities of ouabain.


Bretylium may increase the bradycardic activities of Ivabradine.


labetalol may increase the bradycardic activities of midodrine.


digoxin may increase the bradycardic activities of DEXMEDETOMIDINE.


Isoflurophate may increase the bradycardic activities of acebutolol.


metoprolol may increase the bradycardic activities of Lanreotide.


Isoflurophate may increase the bradycardic activities of oxprenolol.


Regorafenib may increase the bradycardic activities of oxprenolol.


labetalol may increase the bradycardic activities of rivastigmine.


mefloquine may increase the bradycardic activities of practolol.


Nebivolol may increase the bradycardic activities of rivastigmine.


digoxin may increase the bradycardic activities of labetalol.


methyldopa may increase the bradycardic activities of Lanreotide.


digoxin may increase the bradycardic activities of donepezil.


NEOSTIGMINE may increase the bradycardic activities of LEVOBUNOLOL.


digoxin may increase the bradycardic activities of Pasireotide.


pyridostigmine may increase the bradycardic activities of nadolol.


sotalol may increase the bradycardic activities of deslanoside.


atenolol may increase the bradycardic activities of digoxin.


rivastigmine may increase the bradycardic activities of Pasireotide.


Bretylium may increase the bradycardic activities of ceritinib.


amiodarone may increase the bradycardic activities of alprenolol.


succinylcholine may increase the bradycardic activities of Ethylmorphine.


galanthamine may increase the bradycardic activities of Fingolimod.


LEVOBUNOLOL may increase the bradycardic activities of ceritinib.


amiodarone may increase the bradycardic activities of celiprolol.


Ruxolitinib may increase the bradycardic activities of digoxin.


malathion may increase the bradycardic activities of timolol.


succinylcholine may increase the bradycardic activities of nalbuphine.


decamethonium may increase the bradycardic activities of betaxolol.


physostigmine may increase the bradycardic activities of sotalol.


physostigmine may increase the bradycardic activities of BUPRANOLOL.


succinylcholine may increase the bradycardic activities of buprenorphine.


tubocurarine may increase the bradycardic activities of celiprolol.


DEXMEDETOMIDINE may increase the bradycardic activities of Lanreotide.


Dronedarone may increase the bradycardic activities of LEVOBUNOLOL.


penbutolol may increase the bradycardic activities of Crizotinib.


malathion may increase the bradycardic activities of propranolol.


Octreotide may increase the bradycardic activities of VERAPAMIL.


Regorafenib may increase the bradycardic activities of CARTEOLOL.


BUPRANOLOL may increase the bradycardic activities of midodrine.


pyridostigmine may increase the bradycardic activities of Nebivolol.


Dronedarone may increase the bradycardic activities of BOPINDOLOL.


BENDROFLUMETHIAZIDE may increase the bradycardic activities of propafenone.


metoclopramide may increase the bradycardic activities of propranolol.


physostigmine may increase the bradycardic activities of timolol.


oxprenolol may increase the bradycardic activities of digoxin.


Tofacitinib may increase the bradycardic activities of VERAPAMIL.


succinylcholine may increase the bradycardic activities of oxycodone.


rivastigmine may increase the bradycardic activities of amiodarone.


Echothiophate may increase the bradycardic activities of LEVOBUNOLOL.


disopyramide may increase the bradycardic activities of penbutolol.


penbutolol may increase the bradycardic activities of Fingolimod.


nadolol may increase the bradycardic activities of Lanreotide.


Octreotide may increase the bradycardic activities of betaxolol.


penbutolol may increase the bradycardic activities of digitoxin.


Bretylium may increase the bradycardic activities of SUFENTANIL.


propranolol may increase the bradycardic activities of midodrine.


DEXMEDETOMIDINE may increase the bradycardic activities of galanthamine.


GALLAMINE TRIETHIODIDE may increase the bradycardic activities of ESMOLOL.


Demecarium may increase the bradycardic activities of practolol.


Demecarium may increase the bradycardic activities of Nebivolol.


REMIFENTANIL may increase the bradycardic activities of celiprolol.


celiprolol may increase the bradycardic activities of midodrine.


decamethonium may increase the bradycardic activities of timolol.


NEOSTIGMINE may increase the bradycardic activities of BUPRANOLOL.


BENDROFLUMETHIAZIDE may increase the bradycardic activities of donepezil.


REMIFENTANIL may increase the bradycardic activities of BUPRANOLOL.


DEXMEDETOMIDINE may increase the bradycardic activities of donepezil.


tubocurarine may increase the bradycardic activities of BISOPROLOL.


tubocurarine may increase the bradycardic activities of labetalol.


galanthamine may increase the bradycardic activities of acebutolol.


DEXMEDETOMIDINE may increase the bradycardic activities of Pasireotide.


digoxin may increase the bradycardic activities of tizanidine.


metoclopramide may increase the bradycardic activities of BUPRANOLOL.


memantine may increase the bradycardic activities of CARTEOLOL.


VERAPAMIL may increase the bradycardic activities of Pasireotide.


decamethonium may increase the bradycardic activities of celiprolol.


Echothiophate may increase the bradycardic activities of atenolol.


mefloquine may increase the bradycardic activities of nadolol.


malathion may increase the bradycardic activities of sotalol.


succinylcholine may increase the bradycardic activities of Normethadone.


metoclopramide may increase the bradycardic activities of BOPINDOLOL.


Bretylium may increase the bradycardic activities of Dronedarone.


decamethonium may increase the bradycardic activities of nadolol.


SUFENTANIL may increase the bradycardic activities of nadolol.


dipyridamole may increase the bradycardic activities of penbutolol.


clonidine may increase the bradycardic activities of rivastigmine.


GUANFACINE may increase the bradycardic activities of Fingolimod.


Isoflurophate may increase the bradycardic activities of BUPRANOLOL.


Ruxolitinib may increase the bradycardic activities of penbutolol.


dipyridamole may increase the bradycardic activities of labetalol.


tubocurarine may increase the bradycardic activities of Metipranolol.


ALFENTANIL may increase the bradycardic activities of Nebivolol.


digoxin may increase the bradycardic activities of Metipranolol.


tubocurarine may increase the bradycardic activities of sotalol.


CARTEOLOL may increase the bradycardic activities of digitoxin.


Demecarium may increase the bradycardic activities of sotalol.


Octreotide may increase the bradycardic activities of clonidine.


propranolol may increase the bradycardic activities of rivastigmine.


Octreotide may increase the bradycardic activities of propranolol.


amiodarone may increase the bradycardic activities of nadolol.


decamethonium may increase the bradycardic activities of propranolol.


celiprolol may increase the bradycardic activities of Fingolimod.


Demecarium may increase the bradycardic activities of celiprolol.


metoclopramide may increase the bradycardic activities of practolol.


GALLAMINE TRIETHIODIDE may increase the bradycardic activities of oxprenolol.


Echothiophate may increase the bradycardic activities of betaxolol.


Regorafenib may increase the bradycardic activities of celiprolol.


GALLAMINE TRIETHIODIDE may increase the bradycardic activities of Arotinolol.


Metipranolol may increase the bradycardic activities of Crizotinib.


penbutolol may increase the bradycardic activities of deslanoside.


metoclopramide may increase the bradycardic activities of carvedilol.


metoclopramide may increase the bradycardic activities of celiprolol.


donepezil may increase the bradycardic activities of Bevantolol.


edrophonium may increase the bradycardic activities of BOPINDOLOL.


Ruxolitinib may increase the bradycardic activities of timolol.


amiodarone may increase the bradycardic activities of timolol.


ambenonium may increase the bradycardic activities of metoprolol.


Bretylium may increase the bradycardic activities of galanthamine.


succinylcholine may increase the bradycardic activities of codeine.


pyridostigmine may increase the bradycardic activities of propranolol.


mefloquine may increase the bradycardic activities of BUPRANOLOL.


edrophonium may increase the bradycardic activities of alprenolol.


DEXMEDETOMIDINE may increase the bradycardic activities of SUFENTANIL.


betaxolol may increase the bradycardic activities of ceritinib.


diltiazem may increase the bradycardic activities of midodrine.


Metipranolol may increase the bradycardic activities of Pasireotide.


Lanreotide may increase the bradycardic activities of Ivabradine.


oxprenolol may increase the bradycardic activities of Fingolimod.


Tofacitinib may increase the bradycardic activities of tizanidine.


Octreotide may increase the bradycardic activities of acebutolol.


propranolol may increase the bradycardic activities of Pasireotide.


malathion may increase the bradycardic activities of BISOPROLOL.


clonidine may increase the bradycardic activities of Fingolimod.


tubocurarine may increase the bradycardic activities of BOPINDOLOL.


Demecarium may increase the bradycardic activities of propranolol.


dipyridamole may increase the bradycardic activities of CARTEOLOL.


Bretylium may increase the bradycardic activities of sotalol.


Echothiophate may increase the bradycardic activities of Arotinolol.


LEVOBUNOLOL may increase the bradycardic activities of Pasireotide.


galanthamine may increase the bradycardic activities of celiprolol.


Regorafenib may increase the bradycardic activities of Arotinolol.


Telithromycin may increase the bradycardic activities of VERAPAMIL.


Ruxolitinib may increase the bradycardic activities of acebutolol.


DEXMEDETOMIDINE may increase the bradycardic activities of amiodarone.


Tofacitinib may increase the bradycardic activities of labetalol.


donepezil may increase the bradycardic activities of propafenone.


Regorafenib may increase the bradycardic activities of digoxin.


GALLAMINE TRIETHIODIDE may increase the bradycardic activities of carvedilol.


Lanreotide may increase the bradycardic activities of Fingolimod.


ESMOLOL may increase the bradycardic activities of Fingolimod.


Bretylium may increase the bradycardic activities of acebutolol.


edrophonium may increase the bradycardic activities of nadolol.


NEOSTIGMINE may increase the bradycardic activities of ESMOLOL.


Demecarium may increase the bradycardic activities of Bevantolol.


Isoflurophate may increase the bradycardic activities of carvedilol.


sotalol may increase the bradycardic activities of acetyldigitoxin.


digoxin may increase the bradycardic activities of methyldopa.


ESMOLOL may increase the bradycardic activities of Crizotinib.


pyridostigmine may increase the bradycardic activities of alprenolol.


propranolol may increase the bradycardic activities of Fingolimod.


donepezil may increase the bradycardic activities of Arotinolol.


decamethonium may increase the bradycardic activities of alprenolol.


CARTEOLOL may increase the bradycardic activities of Fingolimod.


Demecarium may increase the bradycardic activities of Arotinolol.


BISOPROLOL may increase the bradycardic activities of ouabain.


physostigmine may increase the bradycardic activities of carvedilol.


Echothiophate may increase the bradycardic activities of alprenolol.


Dronedarone may increase the bradycardic activities of Ivabradine.


Arotinolol may increase the bradycardic activities of midodrine.


galanthamine may increase the bradycardic activities of SUFENTANIL.


metoprolol may increase the bradycardic activities of digoxin.


CARTEOLOL may increase the bradycardic activities of Crizotinib.


SUFENTANIL may increase the bradycardic activities of methyldopa.


memantine may increase the bradycardic activities of penbutolol.


Tofacitinib may increase the bradycardic activities of ESMOLOL.


Demecarium may increase the bradycardic activities of penbutolol.


VERAPAMIL may increase the bradycardic activities of rivastigmine.


physostigmine may increase the bradycardic activities of acebutolol.


ESMOLOL may increase the bradycardic activities of ouabain.


Demecarium may increase the bradycardic activities of atenolol.


disopyramide may increase the bradycardic activities of atenolol.


GALLAMINE TRIETHIODIDE may increase the bradycardic activities of CARTEOLOL.


mefloquine may increase the bradycardic activities of Nebivolol.


memantine may increase the bradycardic activities of LEVOBUNOLOL.


tubocurarine may increase the bradycardic activities of BUPRANOLOL.


edrophonium may increase the bradycardic activities of Bevantolol.


oxprenolol may increase the bradycardic activities of midodrine.


edrophonium may increase the bradycardic activities of practolol.


penbutolol may increase the bradycardic activities of midodrine.


labetalol may increase the bradycardic activities of ceritinib.


memantine may increase the bradycardic activities of acebutolol.


Tofacitinib may increase the bradycardic activities of methyldopa.


Demecarium may increase the bradycardic activities of acebutolol.


atenolol may increase the bradycardic activities of ceritinib.


Echothiophate may increase the bradycardic activities of metoprolol.


ESMOLOL may increase the bradycardic activities of rivastigmine.


Octreotide may increase the bradycardic activities of nadolol.


celiprolol may increase the bradycardic activities of deslanoside.


physostigmine may increase the bradycardic activities of betaxolol.


timolol may increase the bradycardic activities of ceritinib.


Metipranolol may increase the bradycardic activities of ceritinib.


decamethonium may increase the bradycardic activities of atenolol.


Bretylium may increase the bradycardic activities of penbutolol.


digoxin may increase the bradycardic activities of Ivabradine.


Bevantolol may increase the bradycardic activities of midodrine.


sotalol may increase the bradycardic activities of Lanreotide.


GUANFACINE may increase the bradycardic activities of propafenone.


atenolol may increase the bradycardic activities of midodrine.


CARTEOLOL may increase the bradycardic activities of rivastigmine.


memantine may increase the bradycardic activities of sotalol.


Tofacitinib may increase the bradycardic activities of rivastigmine.


practolol may increase the bradycardic activities of digoxin.


pyridostigmine may increase the bradycardic activities of metoprolol.


pyridostigmine may increase the bradycardic activities of BISOPROLOL.


galanthamine may increase the bradycardic activities of BUPRANOLOL.


Tofacitinib may increase the bradycardic activities of nadolol.


rivastigmine may increase the bradycardic activities of Fingolimod.


NEOSTIGMINE may increase the bradycardic activities of acebutolol.


ALFENTANIL may increase the bradycardic activities of metoprolol.


clonidine may increase the bradycardic activities of donepezil.


Ruxolitinib may increase the bradycardic activities of SUFENTANIL.


SUFENTANIL may increase the bradycardic activities of penbutolol.


Pasireotide may increase the bradycardic activities of Fingolimod.


ALFENTANIL may increase the bradycardic activities of BOPINDOLOL.


mefloquine may increase the bradycardic activities of atenolol.


malathion may increase the bradycardic activities of carvedilol.


Ruxolitinib may increase the bradycardic activities of ESMOLOL.


galanthamine may increase the bradycardic activities of Metipranolol.


amiodarone may increase the bradycardic activities of Ivabradine.


ambenonium may increase the bradycardic activities of Metipranolol.


ALFENTANIL may increase the bradycardic activities of BUPRANOLOL.


oxprenolol may increase the bradycardic activities of rivastigmine.


amiodarone may increase the bradycardic activities of BUPRANOLOL.


pyridostigmine may increase the bradycardic activities of Metipranolol.


Dronedarone may increase the bradycardic activities of Lanreotide.


Regorafenib may increase the bradycardic activities of VERAPAMIL.


acebutolol may increase the bradycardic activities of acetyldigitoxin.


Metipranolol may increase the bradycardic activities of acetyldigitoxin.


donepezil may increase the bradycardic activities of CARTEOLOL.


Dronedarone may increase the bradycardic activities of Nebivolol.


Tofacitinib may increase the bradycardic activities of CARTEOLOL.


ambenonium may increase the bradycardic activities of practolol.


ambenonium may increase the bradycardic activities of Bevantolol.


alprenolol may increase the bradycardic activities of deslanoside.


celiprolol may increase the bradycardic activities of rivastigmine.


mefloquine may increase the bradycardic activities of alprenolol.


physostigmine may increase the bradycardic activities of metoprolol.


BOPINDOLOL may increase the bradycardic activities of rivastigmine.


carvedilol may increase the bradycardic activities of digitoxin.


tubocurarine may increase the bradycardic activities of alprenolol.


Tofacitinib may increase the bradycardic activities of LEVOBUNOLOL.


disopyramide may increase the bradycardic activities of LEVOBUNOLOL.


malathion may increase the bradycardic activities of betaxolol.


succinylcholine may increase the bradycardic activities of DIPHENOXYLATE.


Echothiophate may increase the bradycardic activities of penbutolol.


decamethonium may increase the bradycardic activities of BUPRANOLOL.


Regorafenib may increase the bradycardic activities of Metipranolol.


Bretylium may increase the bradycardic activities of methyldopa.


NEOSTIGMINE may increase the bradycardic activities of BISOPROLOL.


Regorafenib may increase the bradycardic activities of LEVOBUNOLOL.


donepezil may increase the bradycardic activities of ESMOLOL.


mefloquine may increase the bradycardic activities of BISOPROLOL.


amiodarone may increase the bradycardic activities of atenolol.


Ruxolitinib may increase the bradycardic activities of atenolol.


atenolol may increase the bradycardic activities of digitoxin.


donepezil may increase the bradycardic activities of penbutolol.


GALLAMINE TRIETHIODIDE may increase the bradycardic activities of labetalol.


Isoflurophate may increase the bradycardic activities of Bevantolol.


nadolol may increase the bradycardic activities of rivastigmine.


Isoflurophate may increase the bradycardic activities of practolol.


atenolol may increase the bradycardic activities of Lanreotide.


Isoflurophate may increase the bradycardic activities of penbutolol.


Arotinolol may increase the bradycardic activities of digitoxin.


Bretylium may increase the bradycardic activities of CARTEOLOL.


succinylcholine may increase the bradycardic activities of oxymorphone.


Echothiophate may increase the bradycardic activities of CARTEOLOL.


donepezil may increase the bradycardic activities of Lanreotide.


Regorafenib may increase the bradycardic activities of BISOPROLOL.


propranolol may increase the bradycardic activities of deslanoside.


malathion may increase the bradycardic activities of Nebivolol.


GUANFACINE may increase the bradycardic activities of Pasireotide.


timolol may increase the bradycardic activities of Lanreotide.


memantine may increase the bradycardic activities of Arotinolol.


Regorafenib may increase the bradycardic activities of betaxolol.


tubocurarine may increase the bradycardic activities of metoprolol.


REMIFENTANIL may increase the bradycardic activities of BOPINDOLOL.


ambenonium may increase the bradycardic activities of LEVOBUNOLOL.


decamethonium may increase the bradycardic activities of CARTEOLOL.


tubocurarine may increase the bradycardic activities of Nebivolol.


Nebivolol may increase the bradycardic activities of midodrine.


Ruxolitinib may increase the bradycardic activities of BISOPROLOL.


nadolol may increase the bradycardic activities of deslanoside.


Octreotide may increase the bradycardic activities of CARTEOLOL.


Ruxolitinib may increase the bradycardic activities of CARTEOLOL.


Tofacitinib may increase the bradycardic activities of acebutolol.


malathion may increase the bradycardic activities of metoprolol.


Regorafenib may increase the bradycardic activities of Ivabradine.


physostigmine may increase the bradycardic activities of celiprolol.


Echothiophate may increase the bradycardic activities of Metipranolol.


nadolol may increase the bradycardic activities of acetyldigitoxin.


galanthamine may increase the bradycardic activities of nadolol.


alprenolol may increase the bradycardic activities of Fingolimod.


nadolol may increase the bradycardic activities of midodrine.


galanthamine may increase the bradycardic activities of atenolol.


NEOSTIGMINE may increase the bradycardic activities of timolol.


ambenonium may increase the bradycardic activities of sotalol.


Octreotide may increase the bradycardic activities of Fingolimod.


ambenonium may increase the bradycardic activities of atenolol.


Regorafenib may increase the bradycardic activities of carvedilol.


Regorafenib may increase the bradycardic activities of atenolol.


practolol may increase the bradycardic activities of digitoxin.


methyldopa may increase the bradycardic activities of propafenone.


digoxin may increase the bradycardic activities of midodrine.


mefloquine may increase the bradycardic activities of acebutolol.


Tofacitinib may increase the bradycardic activities of SUFENTANIL.


Demecarium may increase the bradycardic activities of timolol.


Bretylium may increase the bradycardic activities of Fingolimod.


disopyramide may increase the bradycardic activities of acebutolol.


Bretylium may increase the bradycardic activities of Crizotinib.


Nebivolol may increase the bradycardic activities of deslanoside.


BOPINDOLOL may increase the bradycardic activities of digoxin.


atenolol may increase the bradycardic activities of ouabain.


edrophonium may increase the bradycardic activities of Nebivolol.


GALLAMINE TRIETHIODIDE may increase the bradycardic activities of atenolol.


ALFENTANIL may increase the bradycardic activities of practolol.


ALFENTANIL may increase the bradycardic activities of Bevantolol.


dipyridamole may increase the bradycardic activities of propranolol.


succinylcholine may increase the bradycardic activities of meperidine.


amiodarone may increase the bradycardic activities of LEVOBUNOLOL.


SUFENTANIL may increase the bradycardic activities of acebutolol.


timolol may increase the bradycardic activities of digitoxin.


propranolol may increase the bradycardic activities of acetyldigitoxin.


disopyramide may increase the bradycardic activities of labetalol.


ESMOLOL may increase the bradycardic activities of SUFENTANIL.


Nebivolol may increase the bradycardic activities of ouabain.


Tofacitinib may increase the bradycardic activities of Dronedarone.


succinylcholine may increase the bradycardic activities of levorphanol.


memantine may increase the bradycardic activities of practolol.


CARTEOLOL may increase the bradycardic activities of SUFENTANIL.


GALLAMINE TRIETHIODIDE may increase the bradycardic activities of nadolol.


galanthamine may increase the bradycardic activities of alprenolol.


SUFENTANIL may increase the bradycardic activities of Lanreotide.


BENDROFLUMETHIAZIDE may increase the bradycardic activities of amiodarone.


decamethonium may increase the bradycardic activities of ESMOLOL.


galanthamine may increase the bradycardic activities of Bevantolol.


dipyridamole may increase the bradycardic activities of celiprolol.


Nebivolol may increase the bradycardic activities of digitoxin.


amiodarone may increase the bradycardic activities of sotalol.


Octreotide may increase the bradycardic activities of GUANFACINE.


Octreotide may increase the bradycardic activities of rivastigmine.


mefloquine may increase the bradycardic activities of timolol.


tubocurarine may increase the bradycardic activities of betaxolol.


Nebivolol may increase the bradycardic activities of Lanreotide.


nadolol may increase the bradycardic activities of Ivabradine.


metoprolol may increase the bradycardic activities of acetyldigitoxin.


Tofacitinib may increase the bradycardic activities of galanthamine.


edrophonium may increase the bradycardic activities of atenolol.


digoxin may increase the bradycardic activities of penbutolol.


mefloquine may increase the bradycardic activities of propranolol.


Bretylium may increase the bradycardic activities of Pasireotide.


atenolol may increase the bradycardic activities of acetyldigitoxin.


decamethonium may increase the bradycardic activities of acebutolol.


Bretylium may increase the bradycardic activities of LEVOBUNOLOL.


penbutolol may increase the bradycardic activities of Lanreotide.


donepezil may increase the bradycardic activities of oxprenolol.


rivastigmine may increase the bradycardic activities of Lanreotide.


memantine may increase the bradycardic activities of betaxolol.


rivastigmine may increase the bradycardic activities of Ivabradine.


REMIFENTANIL may increase the bradycardic activities of practolol.


REMIFENTANIL may increase the bradycardic activities of Bevantolol.


practolol may increase the bradycardic activities of acetyldigitoxin.


GALLAMINE TRIETHIODIDE may increase the bradycardic activities of betaxolol.


dipyridamole may increase the bradycardic activities of BISOPROLOL.


tubocurarine may increase the bradycardic activities of LEVOBUNOLOL.


Bretylium may increase the bradycardic activities of donepezil.


pyridostigmine may increase the bradycardic activities of LEVOBUNOLOL.


propranolol may increase the bradycardic activities of Lanreotide.


disopyramide may increase the bradycardic activities of metoprolol.


galanthamine may increase the bradycardic activities of Arotinolol.


Ruxolitinib may increase the bradycardic activities of VERAPAMIL.


VERAPAMIL may increase the bradycardic activities of Lanreotide.


donepezil may increase the bradycardic activities of labetalol.


dipyridamole may increase the bradycardic activities of Arotinolol.


galanthamine may increase the bradycardic activities of BOPINDOLOL.


metoclopramide may increase the bradycardic activities of Arotinolol.


ALFENTANIL may increase the bradycardic activities of sotalol.


amiodarone may increase the bradycardic activities of Metipranolol.


ALFENTANIL may increase the bradycardic activities of atenolol.


edrophonium may increase the bradycardic activities of BISOPROLOL.


decamethonium may increase the bradycardic activities of BOPINDOLOL.


timolol may increase the bradycardic activities of midodrine.


dipyridamole may increase the bradycardic activities of BOPINDOLOL.


Bevantolol may increase the bradycardic activities of digoxin.


amiodarone may increase the bradycardic activities of penbutolol.


propranolol may increase the bradycardic activities of Ivabradine.


betaxolol may increase the bradycardic activities of digoxin.


atenolol may increase the bradycardic activities of deslanoside.


ambenonium may increase the bradycardic activities of propranolol.


Octreotide may increase the bradycardic activities of ESMOLOL.


metoclopramide may increase the bradycardic activities of Bevantolol.


VERAPAMIL may increase the bradycardic activities of Fingolimod.


DEXMEDETOMIDINE may increase the bradycardic activities of Dronedarone.


Ruxolitinib may increase the bradycardic activities of methyldopa.


tubocurarine may increase the bradycardic activities of nadolol.


atenolol may increase the bradycardic activities of Fingolimod.


NEOSTIGMINE may increase the bradycardic activities of Nebivolol.


Nebivolol may increase the bradycardic activities of Ivabradine.


BUPRANOLOL may increase the bradycardic activities of Fingolimod.


Octreotide may increase the bradycardic activities of metoprolol.


Tofacitinib may increase the bradycardic activities of propafenone.


NEOSTIGMINE may increase the bradycardic activities of nadolol.


BUPRANOLOL may increase the bradycardic activities of deslanoside.


decamethonium may increase the bradycardic activities of sotalol.


atenolol may increase the bradycardic activities of Crizotinib.


amiodarone may increase the bradycardic activities of ESMOLOL.


Dronedarone may increase the bradycardic activities of acebutolol.


Isoflurophate may increase the bradycardic activities of celiprolol.


carvedilol may increase the bradycardic activities of Lanreotide.


donepezil may increase the bradycardic activities of Ivabradine.


celiprolol may increase the bradycardic activities of ouabain.


labetalol may increase the bradycardic activities of digitoxin.


Echothiophate may increase the bradycardic activities of carvedilol.


tubocurarine may increase the bradycardic activities of propranolol.


Ruxolitinib may increase the bradycardic activities of Metipranolol.


galanthamine may increase the bradycardic activities of Ivabradine.


Ruxolitinib may increase the bradycardic activities of LEVOBUNOLOL.


Echothiophate may increase the bradycardic activities of labetalol.


digoxin may increase the bradycardic activities of propranolol.


Ruxolitinib may increase the bradycardic activities of carvedilol.


galanthamine may increase the bradycardic activities of timolol.


Pasireotide may increase the bradycardic activities of Ivabradine.


SUFENTANIL may increase the bradycardic activities of donepezil.


betaxolol may increase the bradycardic activities of Ivabradine.


NEOSTIGMINE may increase the bradycardic activities of atenolol.


ambenonium may increase the bradycardic activities of timolol.


acebutolol may increase the bradycardic activities of rivastigmine.


memantine may increase the bradycardic activities of alprenolol.


BISOPROLOL may increase the bradycardic activities of midodrine.


Regorafenib may increase the bradycardic activities of timolol.


Bretylium may increase the bradycardic activities of Octreotide.


Tofacitinib may increase the bradycardic activities of Ivabradine.


ALFENTANIL may increase the bradycardic activities of penbutolol.


nadolol may increase the bradycardic activities of ouabain.


galanthamine may increase the bradycardic activities of rivastigmine.


Echothiophate may increase the bradycardic activities of propranolol.


carvedilol may increase the bradycardic activities of Ivabradine.


carvedilol may increase the bradycardic activities of ouabain.


edrophonium may increase the bradycardic activities of acebutolol.


propranolol may increase the bradycardic activities of digitoxin.


timolol may increase the bradycardic activities of deslanoside.


GALLAMINE TRIETHIODIDE may increase the bradycardic activities of timolol.


GALLAMINE TRIETHIODIDE may increase the bradycardic activities of celiprolol.


rivastigmine may increase the bradycardic activities of GUANFACINE.


SUFENTANIL may increase the bradycardic activities of GUANFACINE.


Nebivolol may increase the bradycardic activities of Fingolimod.


Octreotide may increase the bradycardic activities of BENDROFLUMETHIAZIDE.


sotalol may increase the bradycardic activities of ceritinib.


dipyridamole may increase the bradycardic activities of carvedilol.


acebutolol may increase the bradycardic activities of deslanoside.


Dronedarone may increase the bradycardic activities of practolol.


Dronedarone may increase the bradycardic activities of Bevantolol.


NEOSTIGMINE may increase the bradycardic activities of BOPINDOLOL.


Octreotide may increase the bradycardic activities of labetalol.


galanthamine may increase the bradycardic activities of propranolol.


Nebivolol may increase the bradycardic activities of acetyldigitoxin.


Ruxolitinib may increase the bradycardic activities of donepezil.


BISOPROLOL may increase the bradycardic activities of acetyldigitoxin.


Isoflurophate may increase the bradycardic activities of Metipranolol.


ambenonium may increase the bradycardic activities of betaxolol.


carvedilol may increase the bradycardic activities of deslanoside.


physostigmine may increase the bradycardic activities of labetalol.


mefloquine may increase the bradycardic activities of carvedilol.


Ruxolitinib may increase the bradycardic activities of rivastigmine.


acebutolol may increase the bradycardic activities of midodrine.


edrophonium may increase the bradycardic activities of sotalol.


LEVOBUNOLOL may increase the bradycardic activities of digitoxin.


succinylcholine may increase the bradycardic activities of REMIFENTANIL.


Bretylium may increase the bradycardic activities of Metipranolol.


ambenonium may increase the bradycardic activities of BISOPROLOL.


SUFENTANIL may increase the bradycardic activities of Nebivolol.


amiodarone may increase the bradycardic activities of CARTEOLOL.


Isoflurophate may increase the bradycardic activities of sotalol.


LEVOBUNOLOL may increase the bradycardic activities of acetyldigitoxin.


pyridostigmine may increase the bradycardic activities of betaxolol.


malathion may increase the bradycardic activities of CARTEOLOL.


Regorafenib may increase the bradycardic activities of propranolol.


Ruxolitinib may increase the bradycardic activities of Octreotide.


Bretylium may increase the bradycardic activities of BISOPROLOL.


timolol may increase the bradycardic activities of Crizotinib.


ALFENTANIL may increase the bradycardic activities of propranolol.


BUPRANOLOL may increase the bradycardic activities of digitoxin.


Octreotide may increase the bradycardic activities of methyldopa.


edrophonium may increase the bradycardic activities of timolol.


diltiazem may increase the bradycardic activities of Lanreotide.


Tofacitinib may increase the bradycardic activities of DEXMEDETOMIDINE.


Metipranolol may increase the bradycardic activities of Lanreotide.


SOFOSBUVIR may increase the bradycardic activities of amiodarone.


physostigmine may increase the bradycardic activities of oxprenolol.


Octreotide may increase the bradycardic activities of Ivabradine.


tizanidine may increase the bradycardic activities of Fingolimod.


disopyramide may increase the bradycardic activities of practolol.


Echothiophate may increase the bradycardic activities of oxprenolol.


edrophonium may increase the bradycardic activities of propranolol.


sotalol may increase the bradycardic activities of SUFENTANIL.


physostigmine may increase the bradycardic activities of CARTEOLOL.


Nebivolol may increase the bradycardic activities of Crizotinib.


BUPRANOLOL may increase the bradycardic activities of ouabain.


digoxin may increase the bradycardic activities of carvedilol.


BISOPROLOL may increase the bradycardic activities of digitoxin.


Tofacitinib may increase the bradycardic activities of Lanreotide.


betaxolol may increase the bradycardic activities of SUFENTANIL.


nadolol may increase the bradycardic activities of Pasireotide.


Isoflurophate may increase the bradycardic activities of metoprolol.


Isoflurophate may increase the bradycardic activities of BISOPROLOL.


Isoflurophate may increase the bradycardic activities of labetalol.


donepezil may increase the bradycardic activities of celiprolol.


BISOPROLOL may increase the bradycardic activities of Lanreotide.


REMIFENTANIL may increase the bradycardic activities of alprenolol.


LEVOBUNOLOL may increase the bradycardic activities of Ivabradine.


Regorafenib may increase the bradycardic activities of Bevantolol.


Tofacitinib may increase the bradycardic activities of Nebivolol.


Regorafenib may increase the bradycardic activities of practolol.


Regorafenib may increase the bradycardic activities of penbutolol.


physostigmine may increase the bradycardic activities of penbutolol.


decamethonium may increase the bradycardic activities of carvedilol.


BENDROFLUMETHIAZIDE may increase the bradycardic activities of Crizotinib.


decamethonium may increase the bradycardic activities of practolol.


Bretylium may increase the bradycardic activities of carvedilol.


memantine may increase the bradycardic activities of Metipranolol.


timolol may increase the bradycardic activities of digoxin.


alprenolol may increase the bradycardic activities of digoxin.


digoxin may increase the bradycardic activities of Nebivolol.


malathion may increase the bradycardic activities of labetalol.


betaxolol may increase the bradycardic activities of acetyldigitoxin.


ALFENTANIL may increase the bradycardic activities of timolol.


Regorafenib may increase the bradycardic activities of sotalol.


Regorafenib may increase the bradycardic activities of acebutolol.


acebutolol may increase the bradycardic activities of Ivabradine.


tizanidine may increase the bradycardic activities of SUFENTANIL.


BUPRANOLOL may increase the bradycardic activities of rivastigmine.


Dronedarone may increase the bradycardic activities of sotalol.


clonidine may increase the bradycardic activities of SUFENTANIL.


metoclopramide may increase the bradycardic activities of labetalol.


metoclopramide may increase the bradycardic activities of BISOPROLOL.


pyridostigmine may increase the bradycardic activities of celiprolol.


galanthamine may increase the bradycardic activities of methyldopa.


ambenonium may increase the bradycardic activities of alprenolol.


diltiazem may increase the bradycardic activities of rivastigmine.


NEOSTIGMINE may increase the bradycardic activities of betaxolol.


tizanidine may increase the bradycardic activities of rivastigmine.


Isoflurophate may increase the bradycardic activities of alprenolol.


memantine may increase the bradycardic activities of BOPINDOLOL.


Bretylium may increase the bradycardic activities of atenolol.


SUFENTANIL may increase the bradycardic activities of celiprolol.


Bretylium may increase the bradycardic activities of VERAPAMIL.


oxprenolol may increase the bradycardic activities of acetyldigitoxin.


LEVOBUNOLOL may increase the bradycardic activities of Lanreotide.


GALLAMINE TRIETHIODIDE may increase the bradycardic activities of propranolol.


memantine may increase the bradycardic activities of BUPRANOLOL.


ambenonium may increase the bradycardic activities of BOPINDOLOL.


mefloquine may increase the bradycardic activities of Metipranolol.


malathion may increase the bradycardic activities of ESMOLOL.


dipyridamole may increase the bradycardic activities of sotalol.


practolol may increase the bradycardic activities of deslanoside.


ambenonium may increase the bradycardic activities of BUPRANOLOL.


ALFENTANIL may increase the bradycardic activities of betaxolol.


metoprolol may increase the bradycardic activities of deslanoside.


Octreotide may increase the bradycardic activities of Nebivolol.


disopyramide may increase the bradycardic activities of oxprenolol.


DEXMEDETOMIDINE may increase the bradycardic activities of propafenone.


propranolol may increase the bradycardic activities of SUFENTANIL.


Ruxolitinib may increase the bradycardic activities of DEXMEDETOMIDINE.


SUFENTANIL may increase the bradycardic activities of LEVOBUNOLOL.


memantine may increase the bradycardic activities of celiprolol.


disopyramide may increase the bradycardic activities of sotalol.


ALFENTANIL may increase the bradycardic activities of acebutolol.


ALFENTANIL may increase the bradycardic activities of BISOPROLOL.


tubocurarine may increase the bradycardic activities of Bevantolol.


mefloquine may increase the bradycardic activities of betaxolol.


metoclopramide may increase the bradycardic activities of timolol.


physostigmine may increase the bradycardic activities of ESMOLOL.


ambenonium may increase the bradycardic activities of penbutolol.


malathion may increase the bradycardic activities of Metipranolol.


Ruxolitinib may increase the bradycardic activities of Ivabradine.


physostigmine may increase the bradycardic activities of practolol.


succinylcholine may increase the bradycardic activities of Tramadol.


ambenonium may increase the bradycardic activities of carvedilol.


donepezil may increase the bradycardic activities of nadolol.


digoxin may increase the bradycardic activities of LEVOBUNOLOL.


Bretylium may increase the bradycardic activities of BENDROFLUMETHIAZIDE.


donepezil may increase the bradycardic activities of atenolol.


BUPRANOLOL may increase the bradycardic activities of acetyldigitoxin.


CARTEOLOL may increase the bradycardic activities of acetyldigitoxin.


Demecarium may increase the bradycardic activities of alprenolol.


decamethonium may increase the bradycardic activities of Arotinolol.


ALFENTANIL may increase the bradycardic activities of Metipranolol.


donepezil may increase the bradycardic activities of Pasireotide.


celiprolol may increase the bradycardic activities of digoxin.


Tofacitinib may increase the bradycardic activities of GUANFACINE.


VERAPAMIL may increase the bradycardic activities of midodrine.


methyldopa may increase the bradycardic activities of rivastigmine.


NEOSTIGMINE may increase the bradycardic activities of alprenolol.


tubocurarine may increase the bradycardic activities of timolol.


ESMOLOL may increase the bradycardic activities of deslanoside.


SUFENTANIL may increase the bradycardic activities of practolol.


SUFENTANIL may increase the bradycardic activities of Bevantolol.


oxprenolol may increase the bradycardic activities of digitoxin.


Regorafenib may increase the bradycardic activities of Nebivolol.


carvedilol may increase the bradycardic activities of midodrine.


Isoflurophate may increase the bradycardic activities of LEVOBUNOLOL.


digoxin may increase the bradycardic activities of BISOPROLOL.


mefloquine may increase the bradycardic activities of penbutolol.


Arotinolol may increase the bradycardic activities of ouabain.


SUFENTANIL may increase the bradycardic activities of BUPRANOLOL.


Bretylium may increase the bradycardic activities of rivastigmine.


CARTEOLOL may increase the bradycardic activities of deslanoside.


memantine may increase the bradycardic activities of atenolol.


tubocurarine may increase the bradycardic activities of CARTEOLOL.


rivastigmine may increase the bradycardic activities of Crizotinib.


sotalol may increase the bradycardic activities of Fingolimod.


galanthamine may increase the bradycardic activities of LEVOBUNOLOL.


edrophonium may increase the bradycardic activities of carvedilol.


dipyridamole may increase the bradycardic activities of ESMOLOL.


Octreotide may increase the bradycardic activities of tizanidine.


sotalol may increase the bradycardic activities of Crizotinib.


galanthamine may increase the bradycardic activities of BISOPROLOL.


NEOSTIGMINE may increase the bradycardic activities of metoprolol.


mefloquine may increase the bradycardic activities of labetalol.


rivastigmine may increase the bradycardic activities of ceritinib.


GUANFACINE may increase the bradycardic activities of Lanreotide.


tubocurarine may increase the bradycardic activities of oxprenolol.


decamethonium may increase the bradycardic activities of Bevantolol.


amiodarone may increase the bradycardic activities of Arotinolol.


galanthamine may increase the bradycardic activities of ESMOLOL.


acebutolol may increase the bradycardic activities of ouabain.


decamethonium may increase the bradycardic activities of penbutolol.


galanthamine may increase the bradycardic activities of labetalol.


Dronedarone may increase the bradycardic activities of propranolol.


Tofacitinib may increase the bradycardic activities of metoprolol.


Demecarium may increase the bradycardic activities of metoprolol.


SUFENTANIL may increase the bradycardic activities of BOPINDOLOL.


digoxin may increase the bradycardic activities of Fingolimod.


memantine may increase the bradycardic activities of Nebivolol.


Echothiophate may increase the bradycardic activities of practolol.


digoxin may increase the bradycardic activities of CARTEOLOL.


Echothiophate may increase the bradycardic activities of Bevantolol.


disopyramide may increase the bradycardic activities of Nebivolol.


dipyridamole may increase the bradycardic activities of metoprolol.


CARTEOLOL may increase the bradycardic activities of ouabain.


VERAPAMIL may increase the bradycardic activities of Ivabradine.


SUFENTANIL may increase the bradycardic activities of propafenone.


digoxin may increase the bradycardic activities of acebutolol.


ESMOLOL may increase the bradycardic activities of digitoxin.


penbutolol may increase the bradycardic activities of ceritinib.


brimonidine may increase the bradycardic activities of digoxin.


Echothiophate may increase the bradycardic activities of sotalol.


chlorthalidone may increase the hyponatremic activities of citalopram.


methyclothiazide may increase the hyponatremic activities of fluoxetine.


chlorthalidone may increase the hyponatremic activities of sertraline.


hydroflumethiazide may increase the hyponatremic activities of fluoxetine.


polythiazide may increase the hyponatremic activities of Levomilnacipran.


QUINETHAZONE may increase the hyponatremic activities of fluvoxamine.


chlorothiazide may increase the hyponatremic activities of fluvoxamine.


metolazone may increase the hyponatremic activities of paroxetine.


chlorthalidone may increase the hyponatremic activities of venlafaxine.


hydrochlorothiazide may increase the hyponatremic activities of Levomilnacipran.


indapamide may increase the hyponatremic activities of Milnacipran.


hydroflumethiazide may increase the hyponatremic activities of fluvoxamine.


trichlormethiazide may increase the hyponatremic activities of citalopram.


hydroflumethiazide may increase the hyponatremic activities of venlafaxine.


trichlormethiazide may increase the hyponatremic activities of sertraline.


polythiazide may increase the hyponatremic activities of paroxetine.


hydroflumethiazide may increase the hyponatremic activities of Escitalopram.


chlorthalidone may increase the hyponatremic activities of Levomilnacipran.


chlorothiazide may increase the hyponatremic activities of paroxetine.


polythiazide may increase the hyponatremic activities of Escitalopram.


hydrochlorothiazide may increase the hyponatremic activities of Milnacipran.


hydrochlorothiazide may increase the hyponatremic activities of citalopram.


hydrochlorothiazide may increase the hyponatremic activities of sertraline.


chlorothiazide may increase the hyponatremic activities of Escitalopram.


BENDROFLUMETHIAZIDE may increase the hyponatremic activities of fluoxetine.


trichlormethiazide may increase the hyponatremic activities of venlafaxine.


polythiazide may increase the hyponatremic activities of Milnacipran.


polythiazide may increase the hyponatremic activities of fluvoxamine.


hydrochlorothiazide may increase the hyponatremic activities of venlafaxine.


QUINETHAZONE may increase the hyponatremic activities of nefazodone.


trichlormethiazide may increase the hyponatremic activities of Levomilnacipran.


hydroflumethiazide may increase the hyponatremic activities of sertraline.


QUINETHAZONE may increase the hyponatremic activities of Levomilnacipran.


polythiazide may increase the hyponatremic activities of sertraline.


metolazone may increase the hyponatremic activities of Levomilnacipran.


chlorothiazide may increase the hyponatremic activities of nefazodone.


indapamide may increase the hyponatremic activities of Levomilnacipran.


hydrochlorothiazide may increase the hyponatremic activities of Escitalopram.


chlorthalidone may increase the hyponatremic activities of fluvoxamine.


chlorthalidone may increase the hyponatremic activities of Escitalopram.


chlorthalidone may increase the hyponatremic activities of fluoxetine.


BENDROFLUMETHIAZIDE may increase the hyponatremic activities of fluvoxamine.


methyclothiazide may increase the hyponatremic activities of Levomilnacipran.


chlorthalidone may increase the hyponatremic activities of Milnacipran.


chlorothiazide may increase the hyponatremic activities of Milnacipran.


polythiazide may increase the hyponatremic activities of fluoxetine.


hydrochlorothiazide may increase the hyponatremic activities of fluvoxamine.


methyclothiazide may increase the hyponatremic activities of nefazodone.


metolazone may increase the hyponatremic activities of citalopram.


polythiazide may increase the hyponatremic activities of duloxetine.


metolazone may increase the hyponatremic activities of sertraline.


hydrochlorothiazide may increase the hyponatremic activities of fluoxetine.


methyclothiazide may increase the hyponatremic activities of paroxetine.


trichlormethiazide may increase the hyponatremic activities of fluvoxamine.


hydroflumethiazide may increase the hyponatremic activities of Levomilnacipran.


trichlormethiazide may increase the hyponatremic activities of Escitalopram.


trichlormethiazide may increase the hyponatremic activities of fluoxetine.


trichlormethiazide may increase the hyponatremic activities of duloxetine.


trichlormethiazide may increase the hyponatremic activities of Milnacipran.


polythiazide may increase the hyponatremic activities of citalopram.


metolazone may increase the hyponatremic activities of venlafaxine.


hydroflumethiazide may increase the hyponatremic activities of Milnacipran.


methyclothiazide may increase the hyponatremic activities of Escitalopram.


methyclothiazide may increase the hyponatremic activities of Milnacipran.


BENDROFLUMETHIAZIDE may increase the hyponatremic activities of Escitalopram.


metolazone may increase the hyponatremic activities of Escitalopram.


polythiazide may increase the hyponatremic activities of venlafaxine.


chlorthalidone may increase the hyponatremic activities of paroxetine.


metolazone may increase the hyponatremic activities of Milnacipran.


QUINETHAZONE may increase the hyponatremic activities of fluoxetine.


QUINETHAZONE may increase the hyponatremic activities of duloxetine.


metolazone may increase the hyponatremic activities of fluvoxamine.


QUINETHAZONE may increase the hyponatremic activities of paroxetine.


methyclothiazide may increase the hyponatremic activities of fluvoxamine.


metolazone may increase the hyponatremic activities of fluoxetine.


chlorthalidone may increase the hyponatremic activities of nefazodone.


chlorothiazide may increase the hyponatremic activities of venlafaxine.


hydrochlorothiazide may increase the hyponatremic activities of nefazodone.


trichlormethiazide may increase the hyponatremic activities of paroxetine.


hydroflumethiazide may increase the hyponatremic activities of paroxetine.


hydroflumethiazide may increase the hyponatremic activities of citalopram.


indapamide may increase the hyponatremic activities of sertraline.


hydroflumethiazide may increase the hyponatremic activities of nefazodone.


QUINETHAZONE may increase the hyponatremic activities of sertraline.


BENDROFLUMETHIAZIDE may increase the hyponatremic activities of sertraline.


BENDROFLUMETHIAZIDE may increase the hyponatremic activities of nefazodone.


QUINETHAZONE may increase the hyponatremic activities of citalopram.


chlorothiazide may increase the hyponatremic activities of citalopram.


polythiazide may increase the hyponatremic activities of nefazodone.


hydrochlorothiazide may increase the hyponatremic activities of paroxetine.


QUINETHAZONE may increase the hyponatremic activities of venlafaxine.


trichlormethiazide may increase the hyponatremic activities of nefazodone.


methyclothiazide may increase the hyponatremic activities of citalopram.


chlorothiazide may increase the hyponatremic activities of sertraline.


chlorothiazide may increase the hyponatremic activities of Levomilnacipran.


indapamide may increase the hyponatremic activities of paroxetine.


QUINETHAZONE may increase the hyponatremic activities of Milnacipran.


BENDROFLUMETHIAZIDE may increase the hyponatremic activities of citalopram.


methyclothiazide may increase the hyponatremic activities of venlafaxine.


QUINETHAZONE may increase the hyponatremic activities of Escitalopram.


BENDROFLUMETHIAZIDE may increase the hyponatremic activities of paroxetine.


methyclothiazide may increase the hyponatremic activities of sertraline.


BENDROFLUMETHIAZIDE may increase the hyponatremic activities of venlafaxine.


chlorothiazide may increase the hyponatremic activities of fluoxetine.


BENDROFLUMETHIAZIDE may increase the hyponatremic activities of Milnacipran.


BENDROFLUMETHIAZIDE may increase the hyponatremic activities of Levomilnacipran.


metolazone may increase the hyponatremic activities of nefazodone.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with theobromine.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with D-mannitol.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with AMILORIDE.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with PAMABROM.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with methyclothiazide.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with spironolactone.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with methazolamide.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with Eplerenone.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with Mersalyl.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with cyclothiazide.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with Torasemide.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with bumetanide.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with chlorthalidone.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with indapamide.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with ETHACRYNIC ACID.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with Canrenoic acid.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with QUINETHAZONE.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with polythiazide.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with potassium ion.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with trichlormethiazide.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with triamterene.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with chlorothiazide.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with hydrochlorothiazide.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with Drospirenone.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with BENDROFLUMETHIAZIDE.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with hydroflumethiazide.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with metolazone.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with Tolvaptan.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with Conivaptan.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with Potassium citrate.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with furosemide.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with Efonidipine.


The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with acetazolamide.


tacrolimus may increase the nephrotoxic activities of fenoprofen.


BALSALAZIDE may increase the nephrotoxic activities of fenoprofen.


Colistimethate may increase the nephrotoxic activities of Valrubicin.


mesalamine may increase the nephrotoxic activities of Pimecrolimus.


BALSALAZIDE may increase the nephrotoxic activities of epirizole.


cyclosporin A may increase the nephrotoxic activities of meclofenamic acid.


Naftifine may increase the nephrotoxic activities of Sodium phosphate monobasic.


mesalamine may increase the nephrotoxic activities of celecoxib.


Sodium phosphate monobasic may increase the nephrotoxic activities of metolazone.


cyclosporin A may increase the nephrotoxic activities of Salsalate.


cyclosporin A may increase the nephrotoxic activities of sulfamethoxazole.


cyclosporin A may increase the nephrotoxic activities of BALSALAZIDE.


Olsalazine may increase the nephrotoxic activities of Apremilast.


tacrolimus may increase the nephrotoxic activities of epirizole.


cyclosporin A may increase the nephrotoxic activities of Magnesium salicylate.


Olsalazine may increase the nephrotoxic activities of ETOFENAMATE.


Olsalazine may increase the nephrotoxic activities of fenoprofen.


metrizamide may increase the nephrotoxic activities of amphotericin b.


Olsalazine may increase the nephrotoxic activities of fenbufen.


BALSALAZIDE may increase the nephrotoxic activities of sulfasalazine.


tobramycin may increase the nephrotoxic activities of amphotericin b.


bezafibrate may increase the nephrotoxic activities of cyclosporin A.


Sodium phosphate monobasic may increase the nephrotoxic activities of D-mannitol.


mesalamine may increase the nephrotoxic activities of epirizole.


mycophenolic acid may increase the nephrotoxic activities of Sodium phosphate monobasic.


Sodium phosphate monobasic may increase the nephrotoxic activities of spironolactone.


Olsalazine may increase the nephrotoxic activities of meclofenamic acid.


mesalamine may increase the nephrotoxic activities of niflumic acid.


Olsalazine may increase the nephrotoxic activities of ketoprofen.


Olsalazine may increase the nephrotoxic activities of salicylic acid.


Sodium phosphate monobasic may increase the nephrotoxic activities of Canrenoic acid.


mesalamine may increase the nephrotoxic activities of oxaprozin.


BALSALAZIDE may increase the nephrotoxic activities of Nepafenac.


Sodium phosphate monobasic may increase the nephrotoxic activities of triamterene.


celecoxib may increase the nephrotoxic activities of Sodium phosphate monobasic.


BALSALAZIDE may increase the nephrotoxic activities of Propacetamol.


Valrubicin may increase the nephrotoxic activities of amphotericin b.


Sodium phosphate monobasic may increase the nephrotoxic activities of Drospirenone.


ribostamycin may increase the nephrotoxic activities of amphotericin b.


cyclosporin A may increase the nephrotoxic activities of fenoprofen.


resveratrol may increase the nephrotoxic activities of Sodium phosphate monobasic.


Olsalazine may increase the nephrotoxic activities of SERATRODAST.


Olsalazine may increase the nephrotoxic activities of BENZYDAMINE.


tacrolimus may increase the nephrotoxic activities of Nepafenac.


Sodium phosphate monobasic may increase the nephrotoxic activities of Enalaprilat.


cyclosporin A may increase the nephrotoxic activities of tolmetin.


Olsalazine may increase the nephrotoxic activities of zaltoprofen.


Olsalazine may increase the nephrotoxic activities of Aceclofenac.


mesalamine may increase the nephrotoxic activities of Icatibant.


mesalamine may increase the nephrotoxic activities of fenoprofen.


tacrolimus may increase the nephrotoxic activities of antipyrine.


plicamycin may increase the nephrotoxic activities of D-mannitol.


cyclosporin A may increase the nephrotoxic activities of tolfenamic acid.


cyclosporin A may increase the nephrotoxic activities of Droxicam.


cyclosporin A may increase the nephrotoxic activities of Loxoprofen.


BALSALAZIDE may increase the nephrotoxic activities of Aceclofenac.


cyclosporin A may increase the nephrotoxic activities of doxorubicin.


sulindac may increase the nephrotoxic activities of Sodium phosphate monobasic.


IDARUBICIN may increase the nephrotoxic activities of VANCOMYCIN.


IDARUBICIN may increase the nephrotoxic activities of cisplatin.


cyclosporin A may increase the nephrotoxic activities of CLONIXIN.


Sodium phosphate monobasic may increase the nephrotoxic activities of quinapril.


Sodium phosphate monobasic may increase the nephrotoxic activities of chlorothiazide.


Sodium phosphate monobasic may increase the nephrotoxic activities of bumetanide.


tacrolimus may increase the nephrotoxic activities of meclofenamic acid.


BALSALAZIDE may increase the nephrotoxic activities of nimesulide.


mesalamine may increase the nephrotoxic activities of leflunomide.


Apremilast may increase the nephrotoxic activities of Sodium phosphate monobasic.


Masoprocol may increase the nephrotoxic activities of Sodium phosphate monobasic.


tacrolimus may increase the nephrotoxic activities of ibuprofen.


Valrubicin may increase the nephrotoxic activities of cisplatin.


Valrubicin may increase the nephrotoxic activities of VANCOMYCIN.


antipyrine may increase the nephrotoxic activities of Sodium phosphate monobasic.


Icatibant may increase the nephrotoxic activities of Sodium phosphate monobasic.


plicamycin may increase the nephrotoxic activities of cisplatin.


cyclosporin A may increase the nephrotoxic activities of Etoricoxib.


tacrolimus may increase the nephrotoxic activities of Pimecrolimus.


plicamycin may increase the nephrotoxic activities of VANCOMYCIN.


Colistimethate may increase the nephrotoxic activities of doxorubicin.


cyclosporin A may increase the nephrotoxic activities of ibuprofen.


Colistimethate may increase the nephrotoxic activities of plicamycin.


netilmicin may increase the nephrotoxic activities of foscarnet.


cyclosporin A may increase the nephrotoxic activities of Propacetamol.


doxorubicin may increase the nephrotoxic activities of amphotericin b.


cyclosporin A may increase the nephrotoxic activities of daunorubicin.


BALSALAZIDE may increase the nephrotoxic activities of Pimecrolimus.


tacrolimus may increase the nephrotoxic activities of Apremilast.


doxorubicin may increase the nephrotoxic activities of VANCOMYCIN.


doxorubicin may increase the nephrotoxic activities of cisplatin.


Sodium phosphate monobasic may increase the nephrotoxic activities of acetazolamide.


mesalamine may increase the nephrotoxic activities of zaltoprofen.


mesalamine may increase the nephrotoxic activities of Aceclofenac.


Olsalazine may increase the nephrotoxic activities of indomethacin.


Olsalazine may increase the nephrotoxic activities of mesalamine.


mesalamine may increase the nephrotoxic activities of SERATRODAST.


tacrolimus may increase the nephrotoxic activities of floctafenine.


cisplatin may increase the nephrotoxic activities of Torasemide.


Etofibrate may increase the nephrotoxic activities of cyclosporin A.


streptozocin may increase the nephrotoxic activities of D-mannitol.


BALSALAZIDE may increase the nephrotoxic activities of mycophenolate mofetil.


Olsalazine may increase the nephrotoxic activities of azelastine.


Valrubicin may increase the nephrotoxic activities of D-mannitol.


daunorubicin may increase the nephrotoxic activities of foscarnet.


ketorolac may increase the nephrotoxic activities of Sodium phosphate monobasic.


cyclosporin A may increase the nephrotoxic activities of antipyrine.


Sodium phosphate monobasic may increase the nephrotoxic activities of trandolapril.


paromomycin may increase the nephrotoxic activities of cisplatin.


cyclosporin A may increase the nephrotoxic activities of niflumic acid.


paromomycin may increase the nephrotoxic activities of VANCOMYCIN.


mesalamine may increase the nephrotoxic activities of mycophenolate mofetil.


amikacin may increase the nephrotoxic activities of foscarnet.


BALSALAZIDE may increase the nephrotoxic activities of SERATRODAST.


ADAPALENE may increase the nephrotoxic activities of Sodium phosphate monobasic.


BALSALAZIDE may increase the nephrotoxic activities of zaltoprofen.


tacrolimus may increase the nephrotoxic activities of sulfasalazine.


BALSALAZIDE may increase the nephrotoxic activities of tiaprofenic acid.


Amrubicin may increase the nephrotoxic activities of D-mannitol.


cyclosporin A may increase the nephrotoxic activities of suprofen.


Olsalazine may increase the nephrotoxic activities of Sodium phosphate monobasic.


zaltoprofen may increase the nephrotoxic activities of Sodium phosphate monobasic.


cyclosporin A may increase the nephrotoxic activities of azelastine.


BALSALAZIDE may increase the nephrotoxic activities of ZILEUTON.


cisplatin may increase the nephrotoxic activities of bumetanide.


BALSALAZIDE may increase the nephrotoxic activities of etodolac.


Sodium phosphate monobasic may increase the nephrotoxic activities of losartan.


cyclosporin A may increase the nephrotoxic activities of Choline magnesium trisalicylate.


gemfibrozil may increase the nephrotoxic activities of cyclosporin A.


Sodium phosphate monobasic may increase the nephrotoxic activities of hydroflumethiazide.


BALSALAZIDE may increase the nephrotoxic activities of Droxicam.


Valrubicin may increase the nephrotoxic activities of foscarnet.


BALSALAZIDE may increase the nephrotoxic activities of Salsalate.


cyclosporin A may increase the nephrotoxic activities of Pimecrolimus.


gentamicin may increase the nephrotoxic activities of cisplatin.


metrizamide may increase the nephrotoxic activities of cisplatin.


Sodium phosphate monobasic may increase the nephrotoxic activities of Potassium citrate.


Colistimethate may increase the nephrotoxic activities of daunorubicin.


gentamicin may increase the nephrotoxic activities of VANCOMYCIN.


Iron sucrose may increase the nephrotoxic activities of DIMERCAPROL.


mesalamine may increase the nephrotoxic activities of diflunisal.


Amrubicin may increase the nephrotoxic activities of cisplatin.


Colistimethate may increase the nephrotoxic activities of amikacin.


mesalamine may increase the nephrotoxic activities of mefenamic acid.


Amrubicin may increase the nephrotoxic activities of VANCOMYCIN.


ibuprofen may increase the nephrotoxic activities of Sodium phosphate monobasic.


tacrolimus may increase the nephrotoxic activities of Lumiracoxib.


mesalamine may increase the nephrotoxic activities of Lumiracoxib.


Olsalazine may increase the nephrotoxic activities of Salsalate.


kanamycin may increase the nephrotoxic activities of foscarnet.


Olsalazine may increase the nephrotoxic activities of Magnesium salicylate.


amikacin may increase the nephrotoxic activities of D-mannitol.


mesalamine may increase the nephrotoxic activities of NAPROXEN.


cyclosporin A may increase the nephrotoxic activities of ribostamycin.


Sodium phosphate monobasic may increase the nephrotoxic activities of cyclothiazide.


tacrolimus may increase the nephrotoxic activities of tenoxicam.


Olsalazine may increase the nephrotoxic activities of flurbiprofen.


tacrolimus may increase the nephrotoxic activities of ketorolac.


cyclosporin A may increase the nephrotoxic activities of metrizamide.


ETOFENAMATE may increase the nephrotoxic activities of Sodium phosphate monobasic.


cyclosporin A may increase the nephrotoxic activities of mesalamine.


BALSALAZIDE may increase the nephrotoxic activities of tolfenamic acid.


mesalamine may increase the nephrotoxic activities of mycophenolic acid.


Olsalazine may increase the nephrotoxic activities of Lornoxicam.


tacrolimus may increase the nephrotoxic activities of oxaprozin.


cyclosporin A may increase the nephrotoxic activities of tenoxicam.


Olsalazine may increase the nephrotoxic activities of Choline magnesium trisalicylate.


cyclosporin A may increase the nephrotoxic activities of BENZYDAMINE.


BALSALAZIDE may increase the nephrotoxic activities of Icatibant.


cyclosporin A may increase the nephrotoxic activities of nabumetone.


tacrolimus may increase the nephrotoxic activities of resveratrol.


Colistimethate may increase the nephrotoxic activities of Arbekacin.


tacrolimus may increase the nephrotoxic activities of indomethacin.


BALSALAZIDE may increase the nephrotoxic activities of Apremilast.


Arbekacin may increase the nephrotoxic activities of VANCOMYCIN.


Salsalate may increase the nephrotoxic activities of Sodium phosphate monobasic.


Sodium phosphate monobasic may increase the nephrotoxic activities of Tolvaptan.


Arbekacin may increase the nephrotoxic activities of cisplatin.


tacrolimus may increase the nephrotoxic activities of aspirin.


BALSALAZIDE may increase the nephrotoxic activities of Lumiracoxib.


Olsalazine may increase the nephrotoxic activities of NAPROXEN.


cyclosporin A may increase the nephrotoxic activities of sulfasalazine.


Amrubicin may increase the nephrotoxic activities of amphotericin b.


tacrolimus may increase the nephrotoxic activities of ketoprofen.


Olsalazine may increase the nephrotoxic activities of oxyphenbutazone.


Sodium phosphate monobasic may increase the nephrotoxic activities of furosemide.


streptozocin may increase the nephrotoxic activities of foscarnet.


Sodium phosphate monobasic may increase the nephrotoxic activities of MOEXIPRIL.


Olsalazine may increase the nephrotoxic activities of mefenamic acid.


amphotericin b may increase the nephrotoxic activities of foscarnet.


cyclosporin A may increase the nephrotoxic activities of diclofenac.


mesalamine may increase the nephrotoxic activities of flurbiprofen.


BALSALAZIDE may increase the nephrotoxic activities of oxyphenbutazone.


BALSALAZIDE may increase the nephrotoxic activities of fenbufen.


BALSALAZIDE may increase the nephrotoxic activities of ETOFENAMATE.


cyclosporin A may increase the nephrotoxic activities of ketoprofen.


mesalamine may increase the nephrotoxic activities of Choline magnesium trisalicylate.


mesalamine may increase the nephrotoxic activities of indomethacin.


mesalamine may increase the nephrotoxic activities of Etoricoxib.


BALSALAZIDE may increase the nephrotoxic activities of niflumic acid.


tacrolimus may increase the nephrotoxic activities of fenbufen.


BALSALAZIDE may increase the nephrotoxic activities of oxaprozin.


BALSALAZIDE may increase the nephrotoxic activities of mesalamine.


Sodium phosphate monobasic may increase the nephrotoxic activities of irbesartan.


mesalamine may increase the nephrotoxic activities of salicylamide.


Sodium phosphate monobasic may increase the nephrotoxic activities of trichlormethiazide.


netilmicin may increase the nephrotoxic activities of amphotericin b.


BALSALAZIDE may increase the nephrotoxic activities of mefenamic acid.


cyclosporin A may increase the nephrotoxic activities of Arbekacin.


Olsalazine may increase the nephrotoxic activities of ADAPALENE.


mesalamine may increase the nephrotoxic activities of ETOFENAMATE.


mesalamine may increase the nephrotoxic activities of fenbufen.


Sodium phosphate monobasic may increase the nephrotoxic activities of theobromine.


epirizole may increase the nephrotoxic activities of Sodium phosphate monobasic.


mesalamine may increase the nephrotoxic activities of Apremilast.


Sodium phosphate monobasic may increase the nephrotoxic activities of BENDROFLUMETHIAZIDE.


Olopatadine may increase the nephrotoxic activities of Sodium phosphate monobasic.


nabumetone may increase the nephrotoxic activities of Sodium phosphate monobasic.


FERRIC PYROPHOSPHATE may increase the nephrotoxic activities of DIMERCAPROL.


mesalamine may increase the nephrotoxic activities of carprofen.


cyclosporin A may increase the nephrotoxic activities of resveratrol.


azelastine may increase the nephrotoxic activities of Sodium phosphate monobasic.


aspirin may increase the nephrotoxic activities of Sodium phosphate monobasic.


doxorubicin may increase the nephrotoxic activities of D-mannitol.


tacrolimus may increase the nephrotoxic activities of oxyphenbutazone.


indomethacin may increase the nephrotoxic activities of Sodium phosphate monobasic.


tacrolimus may increase the nephrotoxic activities of etodolac.


Sodium phosphate monobasic may increase the nephrotoxic activities of valsartan.


Sodium phosphate monobasic may increase the nephrotoxic activities of ramipril.


Olsalazine may increase the nephrotoxic activities of carprofen.


BALSALAZIDE may increase the nephrotoxic activities of alclofenac.


BALSALAZIDE may increase the nephrotoxic activities of Naftifine.


tacrolimus may increase the nephrotoxic activities of ZILEUTON.


tobramycin may increase the nephrotoxic activities of D-mannitol.


Sodium phosphate monobasic may increase the nephrotoxic activities of lisinopril.


tacrolimus may increase the nephrotoxic activities of tiaprofenic acid.


tacrolimus may increase the nephrotoxic activities of diclofenac.


IDARUBICIN may increase the nephrotoxic activities of amphotericin b.


metrizamide may increase the nephrotoxic activities of foscarnet.


mycophenolate mofetil may increase the nephrotoxic activities of Sodium phosphate monobasic.


tacrolimus may increase the nephrotoxic activities of SERATRODAST.


bacitracin may increase the nephrotoxic activities of streptomycin.


mesalamine may increase the nephrotoxic activities of Naftifine.


Colistimethate may increase the nephrotoxic activities of Amrubicin.


cyclosporin A may increase the nephrotoxic activities of streptozocin.


tacrolimus may increase the nephrotoxic activities of zaltoprofen.


tacrolimus may increase the nephrotoxic activities of Aceclofenac.


Epirubicin may increase the nephrotoxic activities of VANCOMYCIN.


Epirubicin may increase the nephrotoxic activities of cisplatin.


Colistimethate may increase the nephrotoxic activities of Epirubicin.


daunorubicin may increase the nephrotoxic activities of D-mannitol.


Olsalazine may increase the nephrotoxic activities of etodolac.


Pimecrolimus may increase the nephrotoxic activities of Sodium phosphate monobasic.


cyclosporin A may increase the nephrotoxic activities of acemetacin.


Olsalazine may increase the nephrotoxic activities of ZILEUTON.


acemetacin may increase the nephrotoxic activities of Sodium phosphate monobasic.


gentamicin may increase the nephrotoxic activities of amphotericin b.


BALSALAZIDE may increase the nephrotoxic activities of ketoprofen.


niflumic acid may increase the nephrotoxic activities of Sodium phosphate monobasic.


Sodium phosphate monobasic may increase the nephrotoxic activities of PERINDOPRIL.


Spectinomycin may increase the nephrotoxic activities of foscarnet.


Sodium phosphate monobasic may increase the nephrotoxic activities of Candesartan cilexetil.


BALSALAZIDE may increase the nephrotoxic activities of sulindac.


tacrolimus may increase the nephrotoxic activities of Olsalazine.


Olsalazine may increase the nephrotoxic activities of antipyrine.


tobramycin may increase the nephrotoxic activities of foscarnet.


BALSALAZIDE may increase the nephrotoxic activities of chloroquine.


cyclosporin A may increase the nephrotoxic activities of melphalan.


streptomycin may increase the nephrotoxic activities of VANCOMYCIN.


Sodium phosphate monobasic may increase the nephrotoxic activities of AMILORIDE.


streptomycin may increase the nephrotoxic activities of cisplatin.


daunorubicin may increase the nephrotoxic activities of cisplatin.


daunorubicin may increase the nephrotoxic activities of VANCOMYCIN.


BENZYDAMINE may increase the nephrotoxic activities of Sodium phosphate monobasic.


Olsalazine may increase the nephrotoxic activities of celecoxib.


Sodium phosphate monobasic may increase the nephrotoxic activities of Torasemide.


Olsalazine may increase the nephrotoxic activities of diflunisal.


Sodium phosphate monobasic may increase the nephrotoxic activities of rescinnamine.


cyclosporin A may increase the nephrotoxic activities of Nepafenac.


metrizamide may increase the nephrotoxic activities of VANCOMYCIN.


Sodium phosphate monobasic may increase the nephrotoxic activities of TASOSARTAN.


mesalamine may increase the nephrotoxic activities of Loxoprofen.


cyclosporin A may increase the nephrotoxic activities of etodolac.


FERRIC CITRATE may increase the nephrotoxic activities of DIMERCAPROL.


mesalamine may increase the nephrotoxic activities of Droxicam.


Sodium phosphate monobasic may increase the nephrotoxic activities of cilazapril.


BALSALAZIDE may increase the nephrotoxic activities of indomethacin.


mesalamine may increase the nephrotoxic activities of CLONIXIN.


Sodium phosphate monobasic may increase the nephrotoxic activities of potassium ion.


streptozocin may increase the nephrotoxic activities of cisplatin.


plicamycin may increase the nephrotoxic activities of foscarnet.


VANCOMYCIN may increase the nephrotoxic activities of piperacillin.


tacrolimus may increase the nephrotoxic activities of Propacetamol.


mesalamine may increase the nephrotoxic activities of Lornoxicam.


sulfasalazine may increase the nephrotoxic activities of Sodium phosphate monobasic.


cyclosporin A may increase the nephrotoxic activities of Lumiracoxib.


netilmicin may increase the nephrotoxic activities of D-mannitol.


mesalamine may increase the nephrotoxic activities of ZILEUTON.


mesalamine may increase the nephrotoxic activities of ADAPALENE.


tacrolimus may increase the nephrotoxic activities of nabumetone.


mesalamine may increase the nephrotoxic activities of etodolac.


PIRFENIDONE may increase the nephrotoxic activities of Sodium phosphate monobasic.


cyclosporin A may increase the nephrotoxic activities of nimesulide.


ketoprofen may increase the nephrotoxic activities of Sodium phosphate monobasic.


tacrolimus may increase the nephrotoxic activities of tolfenamic acid.


tacrolimus may increase the nephrotoxic activities of Droxicam.


flurbiprofen may increase the nephrotoxic activities of Sodium phosphate monobasic.


metrizamide may increase the nephrotoxic activities of D-mannitol.


cyclosporin A may increase the nephrotoxic activities of oxyphenbutazone.


Spectinomycin may increase the nephrotoxic activities of VANCOMYCIN.


BALSALAZIDE may increase the nephrotoxic activities of Lornoxicam.


amikacin may increase the nephrotoxic activities of cisplatin.


tacrolimus may increase the nephrotoxic activities of nimesulide.


BALSALAZIDE may increase the nephrotoxic activities of ADAPALENE.


Spectinomycin may increase the nephrotoxic activities of cisplatin.


tacrolimus may increase the nephrotoxic activities of NAPROXEN.


Arbekacin may increase the nephrotoxic activities of D-mannitol.


tacrolimus may increase the nephrotoxic activities of mefenamic acid.


fenofibrate may increase the nephrotoxic activities of tacrolimus.


mesalamine may increase the nephrotoxic activities of Nepafenac.


tacrolimus may increase the nephrotoxic activities of Masoprocol.


BALSALAZIDE may increase the nephrotoxic activities of Masoprocol.


Sodium phosphate monobasic may increase the nephrotoxic activities of Spirapril.


cyclosporin A may increase the nephrotoxic activities of indomethacin.


tacrolimus may increase the nephrotoxic activities of Icatibant.


Epirubicin may increase the nephrotoxic activities of amphotericin b.


Olsalazine may increase the nephrotoxic activities of mycophenolic acid.


Teriflunomide may increase the nephrotoxic activities of Sodium phosphate monobasic.


tacrolimus may increase the nephrotoxic activities of PIRFENIDONE.


tacrolimus may increase the nephrotoxic activities of alclofenac.


alclofenac may increase the nephrotoxic activities of Sodium phosphate monobasic.


mesalamine may increase the nephrotoxic activities of suprofen.


Etoricoxib may increase the nephrotoxic activities of Sodium phosphate monobasic.


Amrubicin may increase the nephrotoxic activities of foscarnet.


cyclosporin A may increase the nephrotoxic activities of Spectinomycin.


cyclosporin A may increase the nephrotoxic activities of mefenamic acid.


Sodium phosphate monobasic may increase the nephrotoxic activities of hydrochlorothiazide.


ribostamycin may increase the nephrotoxic activities of D-mannitol.


cyclosporin A may increase the nephrotoxic activities of oxaprozin.


Olsalazine may increase the nephrotoxic activities of suprofen.


Propacetamol may increase the nephrotoxic activities of Sodium phosphate monobasic.


Aceclofenac may increase the nephrotoxic activities of Sodium phosphate monobasic.


leflunomide may increase the nephrotoxic activities of Sodium phosphate monobasic.


Olsalazine may increase the nephrotoxic activities of leflunomide.


cyclosporin A may increase the nephrotoxic activities of ketorolac.


cyclosporin A may increase the nephrotoxic activities of amikacin.


Olsalazine may increase the nephrotoxic activities of mycophenolate mofetil.


cyclosporin A may increase the nephrotoxic activities of ADAPALENE.


mesalamine may increase the nephrotoxic activities of antipyrine.


Arbekacin may increase the nephrotoxic activities of foscarnet.


fenbufen may increase the nephrotoxic activities of Sodium phosphate monobasic.


ribostamycin may increase the nephrotoxic activities of cisplatin.


Sodium phosphate monobasic may increase the nephrotoxic activities of chlorthalidone.


ribostamycin may increase the nephrotoxic activities of VANCOMYCIN.


oxaprozin may increase the nephrotoxic activities of Sodium phosphate monobasic.


cyclosporin A may increase the nephrotoxic activities of NAPROXEN.


tacrolimus may increase the nephrotoxic activities of chloroquine.


tacrolimus may increase the nephrotoxic activities of sulindac.


Olsalazine may increase the nephrotoxic activities of Masoprocol.


cyclosporin A may increase the nephrotoxic activities of salicylamide.


cyclosporin A may increase the nephrotoxic activities of Masoprocol.


Sodium phosphate monobasic may increase the nephrotoxic activities of ETHACRYNIC ACID.


tacrolimus may increase the nephrotoxic activities of Etoricoxib.


cyclosporin A may increase the nephrotoxic activities of chloroquine.


tacrolimus may increase the nephrotoxic activities of ADAPALENE.


tobramycin may increase the nephrotoxic activities of VANCOMYCIN.


cyclosporin A may increase the nephrotoxic activities of sulindac.


Lornoxicam may increase the nephrotoxic activities of Sodium phosphate monobasic.


tobramycin may increase the nephrotoxic activities of cisplatin.


cyclosporin A may increase the nephrotoxic activities of kanamycin.


mesalamine may increase the nephrotoxic activities of ketoprofen.


cyclosporin A may increase the nephrotoxic activities of IDARUBICIN.


Lumiracoxib may increase the nephrotoxic activities of Sodium phosphate monobasic.


BALSALAZIDE may increase the nephrotoxic activities of diflunisal.


Sodium phosphate monobasic may increase the nephrotoxic activities of benazepril.


gentamicin may increase the nephrotoxic activities of foscarnet.


mesalamine may increase the nephrotoxic activities of sulfasalazine.


tacrolimus may increase the nephrotoxic activities of carprofen.


mesalamine may increase the nephrotoxic activities of tolfenamic acid.


mesalamine may increase the nephrotoxic activities of Masoprocol.


mesalamine may increase the nephrotoxic activities of oxyphenbutazone.


cyclosporin A may increase the nephrotoxic activities of Apremilast.


tacrolimus may increase the nephrotoxic activities of tolmetin.


streptozocin may increase the nephrotoxic activities of VANCOMYCIN.


cyclosporin A may increase the nephrotoxic activities of tiaprofenic acid.


BALSALAZIDE may increase the nephrotoxic activities of Teriflunomide.


BALSALAZIDE may increase the nephrotoxic activities of Choline magnesium trisalicylate.


BALSALAZIDE may increase the nephrotoxic activities of Magnesium salicylate.


tacrolimus may increase the nephrotoxic activities of celecoxib.


cyclosporin A may increase the nephrotoxic activities of foscarnet.


doxorubicin may increase the nephrotoxic activities of foscarnet.


tacrolimus may increase the nephrotoxic activities of BENZYDAMINE.


Droxicam may increase the nephrotoxic activities of Sodium phosphate monobasic.


tacrolimus may increase the nephrotoxic activities of Teriflunomide.


cyclosporin A may increase the nephrotoxic activities of ZILEUTON.


Loxoprofen may increase the nephrotoxic activities of Sodium phosphate monobasic.


bacitracin may increase the nephrotoxic activities of polymyxin b.


meclofenamic acid may increase the nephrotoxic activities of Sodium phosphate monobasic.


Olsalazine may increase the nephrotoxic activities of Icatibant.


cyclosporin A may increase the nephrotoxic activities of netilmicin.


BALSALAZIDE may increase the nephrotoxic activities of PIRFENIDONE.


Olsalazine may increase the nephrotoxic activities of Lumiracoxib.


tacrolimus may increase the nephrotoxic activities of BALSALAZIDE.


cyclosporin A may increase the nephrotoxic activities of SERATRODAST.


cyclosporin A may increase the nephrotoxic activities of paromomycin.


Sodium phosphate monobasic may increase the nephrotoxic activities of Sacubitril.


Sodium phosphate monobasic may increase the nephrotoxic activities of fosinopril.


chloroquine may increase the nephrotoxic activities of Sodium phosphate monobasic.


Olsalazine may increase the nephrotoxic activities of salicylamide.


cyclosporin A may increase the nephrotoxic activities of zaltoprofen.


cyclosporin A may increase the nephrotoxic activities of Aceclofenac.


Olsalazine may increase the nephrotoxic activities of ibuprofen.


cisplatin may increase the nephrotoxic activities of ETHACRYNIC ACID.


Olsalazine may increase the nephrotoxic activities of resveratrol.


cyclosporin A may increase the nephrotoxic activities of fenbufen.


cyclosporin A may increase the nephrotoxic activities of sulfadiazine.


fenofibrate may increase the nephrotoxic activities of cyclosporin A.


bacitracin may increase the nephrotoxic activities of Colistimethate.


tacrolimus may increase the nephrotoxic activities of mycophenolic acid.


tacrolimus may increase the nephrotoxic activities of Lornoxicam.


Epirubicin may increase the nephrotoxic activities of foscarnet.


Olsalazine may increase the nephrotoxic activities of alclofenac.


cyclosporin A may increase the nephrotoxic activities of epirizole.


plicamycin may increase the nephrotoxic activities of amphotericin b.


gentamicin may increase the nephrotoxic activities of D-mannitol.


amikacin may increase the nephrotoxic activities of amphotericin b.


cyclosporin A may increase the nephrotoxic activities of gentamicin.


BALSALAZIDE may increase the nephrotoxic activities of salicylamide.


Colistimethate may increase the nephrotoxic activities of VANCOMYCIN.


tenoxicam may increase the nephrotoxic activities of Sodium phosphate monobasic.


tacrolimus may increase the nephrotoxic activities of foscarnet.


cyclosporin A may increase the nephrotoxic activities of Olsalazine.


cisplatin may increase the nephrotoxic activities of furosemide.


streptomycin may increase the nephrotoxic activities of amphotericin b.


clofibrate may increase the nephrotoxic activities of cyclosporin A.


Olsalazine may increase the nephrotoxic activities of Naftifine.


Olsalazine may increase the nephrotoxic activities of tiaprofenic acid.


streptomycin may increase the nephrotoxic activities of D-mannitol.


mefenamic acid may increase the nephrotoxic activities of Sodium phosphate monobasic.


cyclosporin A may increase the nephrotoxic activities of Icatibant.


streptomycin may increase the nephrotoxic activities of foscarnet.


Sodium phosphate monobasic may increase the nephrotoxic activities of enalapril.


BALSALAZIDE may increase the nephrotoxic activities of carprofen.


mesalamine may increase the nephrotoxic activities of ibuprofen.


BALSALAZIDE may increase the nephrotoxic activities of aspirin.


BALSALAZIDE may increase the nephrotoxic activities of Etoricoxib.


cyclosporin A may increase the nephrotoxic activities of streptomycin.


Sodium phosphate monobasic may increase the nephrotoxic activities of captopril.


paromomycin may increase the nephrotoxic activities of D-mannitol.


cyclosporin A may increase the nephrotoxic activities of plicamycin.


tacrolimus may increase the nephrotoxic activities of diflunisal.


salicylic acid may increase the nephrotoxic activities of Sodium phosphate monobasic.


methotrexate may increase the nephrotoxic activities of foscarnet.


Sodium phosphate monobasic may increase the nephrotoxic activities of Conivaptan.


Sodium phosphate monobasic may increase the nephrotoxic activities of Eprosartan.


PAMIDRONIC ACID may increase the nephrotoxic activities of thalidomide.


Colistimethate may increase the nephrotoxic activities of kanamycin.


BALSALAZIDE may increase the nephrotoxic activities of nabumetone.


Colistimethate may increase the nephrotoxic activities of IDARUBICIN.


BALSALAZIDE may increase the nephrotoxic activities of tenoxicam.


BALSALAZIDE may increase the nephrotoxic activities of tolmetin.


Sodium phosphate monobasic may increase the nephrotoxic activities of PAMABROM.


Olsalazine may increase the nephrotoxic activities of oxaprozin.


mesalamine may increase the nephrotoxic activities of tiaprofenic acid.


Colistimethate may increase the nephrotoxic activities of ribostamycin.


cyclosporin A may increase the nephrotoxic activities of celecoxib.


Sodium phosphate monobasic may increase the nephrotoxic activities of Mersalyl.


oxyphenbutazone may increase the nephrotoxic activities of Sodium phosphate monobasic.


BALSALAZIDE may increase the nephrotoxic activities of BENZYDAMINE.


Spectinomycin may increase the nephrotoxic activities of amphotericin b.


Olsalazine may increase the nephrotoxic activities of nabumetone.


mesalamine may increase the nephrotoxic activities of Sodium phosphate monobasic.


mesalamine may increase the nephrotoxic activities of BENZYDAMINE.


Olsalazine may increase the nephrotoxic activities of tenoxicam.


Olsalazine may increase the nephrotoxic activities of epirizole.


BALSALAZIDE may increase the nephrotoxic activities of Olopatadine.


Colistimethate may increase the nephrotoxic activities of metrizamide.


carprofen may increase the nephrotoxic activities of Sodium phosphate monobasic.


Olsalazine may increase the nephrotoxic activities of BALSALAZIDE.


diflunisal may increase the nephrotoxic activities of Sodium phosphate monobasic.


salicylamide may increase the nephrotoxic activities of Sodium phosphate monobasic.


Fenofibric acid may increase the nephrotoxic activities of cyclosporin A.


Colistimethate may increase the nephrotoxic activities of netilmicin.


tacrolimus may increase the nephrotoxic activities of Loxoprofen.


triamterene may increase the nephrotoxic activities of indomethacin.


suprofen may increase the nephrotoxic activities of Sodium phosphate monobasic.


fenoprofen may increase the nephrotoxic activities of Sodium phosphate monobasic.


cyclosporin A may increase the nephrotoxic activities of carprofen.


Colistimethate may increase the nephrotoxic activities of gentamicin.


BALSALAZIDE may increase the nephrotoxic activities of flurbiprofen.


tacrolimus may increase the nephrotoxic activities of mycophenolate mofetil.


Arbekacin may increase the nephrotoxic activities of amphotericin b.


amikacin may increase the nephrotoxic activities of VANCOMYCIN.


tacrolimus may increase the nephrotoxic activities of Olopatadine.


BALSALAZIDE may increase the nephrotoxic activities of celecoxib.


tolmetin may increase the nephrotoxic activities of Sodium phosphate monobasic.


cyclosporin A may increase the nephrotoxic activities of sulfisoxazole.


tacrolimus may increase the nephrotoxic activities of CLONIXIN.


SERATRODAST may increase the nephrotoxic activities of Sodium phosphate monobasic.


cyclosporin A may increase the nephrotoxic activities of Valrubicin.


Colistimethate may increase the nephrotoxic activities of paromomycin.


cyclosporin A may increase the nephrotoxic activities of Olopatadine.


tacrolimus may increase the nephrotoxic activities of ETOFENAMATE.


cyclosporin A may increase the nephrotoxic activities of Epirubicin.


nimesulide may increase the nephrotoxic activities of Sodium phosphate monobasic.


ribostamycin may increase the nephrotoxic activities of foscarnet.


Colistimethate may increase the nephrotoxic activities of streptozocin.


BALSALAZIDE may increase the nephrotoxic activities of leflunomide.


IDARUBICIN may increase the nephrotoxic activities of foscarnet.


tolfenamic acid may increase the nephrotoxic activities of Sodium phosphate monobasic.


mesalamine may increase the nephrotoxic activities of Salsalate.


Olsalazine may increase the nephrotoxic activities of chloroquine.


floctafenine may increase the nephrotoxic activities of Sodium phosphate monobasic.


Olsalazine may increase the nephrotoxic activities of sulindac.


cyclosporin A may increase the nephrotoxic activities of Amrubicin.


Olsalazine may increase the nephrotoxic activities of Olopatadine.


cyclosporin A may increase the nephrotoxic activities of flurbiprofen.


Olsalazine may increase the nephrotoxic activities of nimesulide.


tacrolimus may increase the nephrotoxic activities of salicylamide.


tacrolimus may increase the nephrotoxic activities of niflumic acid.


BALSALAZIDE may increase the nephrotoxic activities of suprofen.


Sodium phosphate monobasic may increase the nephrotoxic activities of AZILSARTAN MEDOXOMIL.


Sodium phosphate monobasic may increase the nephrotoxic activities of Olmesartan.


BALSALAZIDE may increase the nephrotoxic activities of azelastine.


mesalamine may increase the nephrotoxic activities of salicylic acid.


mesalamine may increase the nephrotoxic activities of meclofenamic acid.


Colistimethate may increase the nephrotoxic activities of streptomycin.


tiaprofenic acid may increase the nephrotoxic activities of Sodium phosphate monobasic.


cyclosporin A may increase the nephrotoxic activities of floctafenine.


Olsalazine may increase the nephrotoxic activities of tolmetin.


Sodium phosphate monobasic may increase the nephrotoxic activities of indapamide.


mesalamine may increase the nephrotoxic activities of tenoxicam.


cyclosporin A may increase the nephrotoxic activities of tobramycin.


cyclosporin A may increase the nephrotoxic activities of amphotericin b.


BALSALAZIDE may increase the nephrotoxic activities of Loxoprofen.


mesalamine may increase the nephrotoxic activities of nabumetone.


BALSALAZIDE may increase the nephrotoxic activities of CLONIXIN.


cyclosporin A may increase the nephrotoxic activities of mycophenolate mofetil.


Spectinomycin may increase the nephrotoxic activities of D-mannitol.


Olsalazine may increase the nephrotoxic activities of Pimecrolimus.


tacrolimus may increase the nephrotoxic activities of acemetacin.


Nepafenac may increase the nephrotoxic activities of Sodium phosphate monobasic.


mesalamine may increase the nephrotoxic activities of Olopatadine.


mesalamine may increase the nephrotoxic activities of sulindac.


mesalamine may increase the nephrotoxic activities of chloroquine.


BALSALAZIDE may increase the nephrotoxic activities of antipyrine.


etodolac may increase the nephrotoxic activities of Sodium phosphate monobasic.


Colistimethate may increase the nephrotoxic activities of Spectinomycin.


Olsalazine may increase the nephrotoxic activities of aspirin.


CLONIXIN may increase the nephrotoxic activities of Sodium phosphate monobasic.


BALSALAZIDE may increase the nephrotoxic activities of Sodium phosphate monobasic.


Choline magnesium trisalicylate may increase the nephrotoxic activities of Sodium phosphate monobasic.


paromomycin may increase the nephrotoxic activities of amphotericin b.


paromomycin may increase the nephrotoxic activities of foscarnet.


streptozocin may increase the nephrotoxic activities of amphotericin b.


mesalamine may increase the nephrotoxic activities of PIRFENIDONE.


BALSALAZIDE may increase the nephrotoxic activities of NAPROXEN.


cyclosporin A may increase the nephrotoxic activities of diflunisal.


Epirubicin may increase the nephrotoxic activities of D-mannitol.


cyclosporin A may increase the nephrotoxic activities of tacrolimus.


cyclosporin A may increase the nephrotoxic activities of aspirin.


kanamycin may increase the nephrotoxic activities of D-mannitol.


Olsalazine may increase the nephrotoxic activities of Propacetamol.


diclofenac may increase the nephrotoxic activities of Sodium phosphate monobasic.


Sodium phosphate monobasic may increase the nephrotoxic activities of methazolamide.


Sodium phosphate monobasic may increase the nephrotoxic activities of Eplerenone.


cyclosporin A may increase the nephrotoxic activities of Lornoxicam.


Olsalazine may increase the nephrotoxic activities of PIRFENIDONE.


mesalamine may increase the nephrotoxic activities of Magnesium salicylate.


cyclosporin A may increase the nephrotoxic activities of PIRFENIDONE.


Colistimethate may increase the nephrotoxic activities of tobramycin.